Evidence map›Paper›PMID 25038206›Full record

ReviewSaudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association

Epidemiology and pattern of antibiotic resistance in Helicobacter pylori: scenario from Saudi Arabia.

Mohammed Rizwan, Nuzhath Fatima, Ayesha Alvi

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07021729 (Comparison of Conventional Clarithromycin Vs Alternative Levofloxacin Based Regimen in Treatment of Helicobacter Pylori Infection), which is not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07021729 phase4not yet recruitingnot on this map

Comparison of Conventional Clarithromycin Vs Alternative Levofloxacin Based Regimen in Treatment of Helicobacter Pylori Infection

TypeinterventionalSponsorRehman Medical Institute - RMIRan2025 to 2026Enrolled156ConditionsHelicobacter Pylori InfectionArmsClarithromycin, Levofloxacin
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Ciprofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: A randomized trial.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2015
    Trial
  3. Persistence ofJournal of clinical medicine · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. GC-MS Profiling, Anti-Plants (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Southern African journal of infectious diseases · 2019
    Article
  13. Article
  14. Efficacy of a bismuth-based quadruple therapy regimen forSaudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Article
  15. Helicobacter pylori: Indian perspective.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Article
  16. Helicobacter pylori: A Common Infection.Journal of family medicine and primary care
    Article
  17. Conclusive strategies for therapy and virotyping of Helicobacter pylori.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Article
  18. In response to "Conclusive strategies for therapy and virotyping of Helicobacter pylori".Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Article
  19. Strategies forSaudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Article
  20. Practice guidelines for the management ofSaudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mohammed Rizwan
Nuzhath Fatima
Ayesha AlviDepartment of Genetics and Molecular Biology, Faculty of Applied Medical Sciences, Jazan University, Jazan, Kingdom of Saudi Arabia.
Jazan University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Helicobacter pylori is recognized as a major cause of gastritis, peptic ulcer, gastric cancer, and mucosa-associated lymphoma. Infection with this gram-negative microaerophile has been treated using combination of antibiotics and proton pump inhibitors for different gastrointestinal diseases. The most commonly used treatment is triple therapy which consists of administration of a proton pump inhibitor, clarithromycin, and amoxicillin. Many factors contribute to treatment failure, but one of the main reasons is development of bacterial antibiotic resistance. The percent prevalence of antibiotic resistance varies among different countries; it appears to be partly determined by the geographic factors and its ability to undergo frequent homologous recombination. The aim of this paper is to review the prevalence of H. pylori infection, association of clinical outcomes with H. pylori genotypes, and current status of antibiotic resistance in H. pylori in Saudi Arabia. It also discusses the different alternative approaches for the treatment of H. pylori using antibiotics. In addition, association of antibiotic resistance with H. pylori virulent genotypes in Saudi population and its underlying resistance mechanism will also be discussed.

Indexed as

Drug Resistance, BacterialGenotypeHelicobacter InfectionsHelicobacter pyloriHumansPrevalenceSaudi Arabia

Identifiers

PMID25038206
PMCPMC4131303
OpenAlexW2066769203

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.